Friday Links

Silicon Valley elite are spending up to $50,000 on genetic tests that claim to predict IQ alongside disease risks in their offspring.

Over the past ten years, biosimilars have saved the U.S. health care system north of $56 billion, with the potential to save an additional $181 billion in the next five years.

Study: existing AI platforms could deliver up to $360 billion in annual cost reductions without harming the quality of care delivered to patients. 

An argument: AI will kill us all.